434 results on '"Yu, Paul B."'
Search Results
52. The Role of Bone Marrow-derived Cells in Pulmonary Arterial Hypertension. What Lies Beneath?
53. Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop
54. Elafin in Pulmonary Arterial Hypertension. Beyond Targeting Elastases
55. Applications of small molecule BMP inhibitors in physiology and disease
56. ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
57. Generation of an induced pluripotent stem cell line (TRNDi012-B) from Fibrodysplasia Ossificans Progressiva (FOP) patient carrying a heterozygous mutation c. 617G > A in the ACVR1 gene
58. A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification
59. Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice
60. Additional file 1 of Suppressed prefrontal cortex oscillations associate with clinical pain in fibrodysplasia ossificans progressiva
61. Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
62. BMP type I receptor inhibition reduces heterotopic ossification
63. Bone Morphogenetic Protein-2 Induces Non-Canonical Inflammatory and Oxidative Pathways in Human Retinal Endothelial Cells
64. BMP Ligand Trap ALK3-Fc Attenuates Osteogenesis and Heterotopic Ossification in Blast-Related Lower Extremity Trauma
65. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia
66. Immunochemical Properties of Anti-Galα1–3Gal Antibodies After Sensitization with Xenogeneic Tissues
67. ST-Segment Elevation Myocardial Infarction Due to Right Coronary Artery Compression by Cardiac Synovial Sarcoma
68. Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
69. Periostin
70. STOPFOP: A European phase II clinical trial using saracatinib to treat FOP
71. Perspectives on Cardiopulmonary Critical Care for Patients With COVID‐19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation
72. BMP9/10 in Pulmonary Vascular Complications of Liver Disease
73. Circulating BMP9 protects the pulmonary endothelium during inflammation-induced lung injury in mice
74. ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
75. Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension
76. Specificity and Function of “Natural” Antibodies in Immunodeficient Subjects: Clues to B Cell Lineage and Development
77. Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitors
78. Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice.
79. Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
80. Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension
81. Isolating pulmonary microvascular endothelial cells ex vivo: Implications for pulmonary arterial hypertension, and a caution on the use of commercial biomaterials
82. Finding the Target: In Silico and Genetic Screening for Mechanistically Novel Drugs in Pulmonary Arterial Hypertension
83. Hapten-Induced Primary and Memory Humoral Responses Are Inhibited by the Infusion of Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab)
84. Decision letter: Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity
85. Update in Pulmonary Vascular Disease 2016 and 2017
86. Career Development of Young Physician–Scientists in the Cardiovascular Sciences
87. Correction for Bagarova et al., “Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation”
88. Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification
89. Coordinated modulation of circulating miR-21 in HIV, HIV-associated pulmonary arterial hypertension, and HIV/HCV co-infection
90. Macrophage Migration Inhibitory Factor as a Novel Biomarker of Portopulmonary Hypertension
91. Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification
92. A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension
93. Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
94. Up‐regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension
95. Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection.
96. Update in Pulmonary Vascular Disease 2016 and 2017.
97. Abstract 19603: Bone Morphogenetic Protein 6 and Oxidized Low-density Lipoprotein Synergistically Recruit Osteogenic Differentiation in Endothelial Cells
98. Targeting BMP signalling in cardiovascular disease and anaemia
99. Bone morphogenetic protein 6 and oxidized low-density lipoprotein synergistically recruit osteogenic differentiation in endothelial cells
100. ACVR1R206Hreceptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.